Gabapentin Capsule
Product Images NDC 49483-605

12 FDA label images from Time Cap Laboratories, Inc · Packaging, Regulatory Labels, and Product Appearance

Product Visual Gallery

This gallery contains 12 technical images submitted to the FDA as part of the official labeling for Gabapentin (NDC 49483-605). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Time Cap Laboratories, Inc, these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

Formula (Gabapentin Figure 06)

Formula (Gabapentin Figure 06)
A formula depicting creatinine clearance (CLCr), calculated using patient's age, weight, serum creatinine levels, and a factor for female patients. The equation includes terms for age in years, weight in kilograms, serum creatinine in mg/dL, and a multiplier of 0.85 for females.*
FDA Label Image

Structure Of Gaba (Gabapentin Figure 01)

Structure Of Gaba (Gabapentin Figure 01)
Chemical structure of gabapentin, showing its cyclohexane ring with amino and carboxyl functional groups.*
FDA Label Image

Figure-2 (Gabapentin Figure 02)

Figure-2 (Gabapentin Figure 02)
A line graph comparing mean pain scores over eight weeks between placebo and gabapentin at 3600 mg/day. The x-axis represents weeks, with a 4-week dose titration period followed by a 4-week fixed dose period. The y-axis shows mean pain scores, with gabapentin demonstrating a gradual decrease compared to placebo.*
FDA Label Image

Figure-3 (Gabapentin Figure 03)

Figure-3 (Gabapentin Figure 03)
A line graph showing mean pain scores over a period of 7 weeks for placebo and two gabapentin dose groups (1800 mg/day and 2400 mg/day). The graph divides the timeline into a 3-week dose titration period and a 4-week fixed dose period. Pain scores decrease over time for both gabapentin groups compared to placebo.*
FDA Label Image

Figure-4 (Gabapentin Figure 04)

Figure-4 (Gabapentin Figure 04)
A bar chart titled 'Proportion of Responders (patients with ≥ 50% reduction in pain score) at Endpoint: Controlled PHN Studies.' It compares responder proportions between placebo (PBO) and gabapentin (GBP) at doses 3600 mg (Study 1), 1800 mg, and 2400 mg (Study 2). Percentages are displayed above bars, showing higher responder rates for gabapentin groups with statistical significance noted.*
FDA Label Image

Image (Gabapentin Figure 05)

Image (Gabapentin Figure 05)
A scatter plot graph showing percentage difference on the y-axis versus daily dose in milligrams on the x-axis, with data points from three studies labeled 'a', 'b', and 'c'. Study a is represented by black squares, study b by grey squares, and study c by white squares. The graph compares differences at daily doses of approximately 600 mg, 900 mg, 1200 mg, and 1800 mg.*
FDA Label Image

Gabapentin-100mg-100s.jpg (Gabapentin 100mg 100s)

Gabapentin-100mg-100s.jpg (Gabapentin 100mg 100s)
Label for Gabapentin Capsules, USP 100 mg by Time-Cap Labs, Inc. The label includes the strength (100 mg), quantity (100 capsules), storage instructions, manufacturer information (Time-Cap Labs, Inc. and Marksans Pharma Ltd.), and a barcode. The label also advises dispensing in a well-closed container and references the package insert for dosage and use details.*
FDA Label Image

Gabapentin-100mg-1000s.jpg (Gabapentin 100mg 1000s)

Gabapentin-100mg-1000s.jpg (Gabapentin 100mg 1000s)
Gabapentin Capsules, USP 100 mg capsule label from Time-Cap Labs, Inc. The label indicates the product contains Gabapentin, 100 mg per capsule, with a quantity of 1000 capsules. It includes storage instructions, manufacturer information (Marksans Pharma Ltd., India), and a barcode. The label is primarily white with purple and red text.*
FDA Label Image

Gabapentin-300mg-1000s.jpg (Gabapentin 300mg 1000s)

Gabapentin-300mg-1000s.jpg (Gabapentin 300mg 1000s)
Label for Gabapentin Capsules USP 300 mg by Time-Cap Labs, Inc. The label states each capsule contains Gabapentin 300 mg and includes storage instructions and manufacturer details. The package contains 1000 capsules and is marked Rx only. The label features the Time-Cap Labs logo and a barcode.*
FDA Label Image

Gabapentin-300mg-100s.jpg (Gabapentin 300mg 100s)

Gabapentin-300mg-100s.jpg (Gabapentin 300mg 100s)
Gabapentin Capsules, USP 300 mg oral capsules label by Time-Cap Labs, Inc. The label states 100 capsules per container. It includes storage instructions to keep at 20° to 25°C with allowable excursions, and dispensing instructions per USP. The label also notes the manufacturer Marksans Pharma Ltd., India.*
FDA Label Image

Gabapentin-400mg-1000s.jpg (Gabapentin 400mg 1000s)

Gabapentin-400mg-1000s.jpg (Gabapentin 400mg 1000s)
Label for Gabapentin Capsules, USP 400 mg by Time-Cap Labs, Inc. The label includes storage instructions, manufacturing details for Time-Cap Labs, Inc. and Marksans Pharma Ltd., and a note for pharmacists to dispense the Medication Guide separately. The package contains 1000 capsules and is marked Rx only.*
FDA Label Image

Gabapentin-400mg-100s.jpg (Gabapentin 400mg 100s)

Gabapentin-400mg-100s.jpg (Gabapentin 400mg 100s)
Label for Gabapentin Capsules, USP 400 mg by Time Cap Labs, Inc. The label displays the brand and generic name, strength, quantity of 100 capsules, and storage instructions. The manufacturer is Marksans Pharma Ltd., India, with Time Cap Labs, Inc. as the labeler in Farmingdale, NY, USA.*

* About these descriptions: Image descriptions on this page are generated by automated AI analysis of the product label images from the manufacturer's FDA label submission (SPL). They are provided for reference only and may contain errors or omissions. Always rely on the printed label itself and the official FDA labeling, and consult a pharmacist or healthcare professional with any questions about this product.